(Q53502534)

English

Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndrome.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndrome. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

14

object named as

Cashman NR

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

author name string

Trojan DA

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Collet J

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Pollak MN

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Shapiro S

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Jubelt B

5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Miller RG

6

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Agre JC

7

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Munsat TL

8

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Hollander D

9

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Tandan R

10

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Robinson A

11

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Finch L

12

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Ducruet T

13

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Journal of the Neurological Sciences

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

182

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

107-115

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Late denervation in patients with antecedent paralytic poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

New concepts of the reinnervated motor unit revealed by vaccine-associated poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Dynamic electromyography and muscle biopsy changes in a 4-year follow-up: study of patients with a history of polio

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Early and late losses of motor units after poliomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Late changes in the motor unit after acute poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Hyposomatomedinemia in men with post-poliomyelitis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Prevalence of low plasma IGF-I in poliomyelitis survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Correlation of Electrophysiology with Pathology, Pathogenesis, and Anticholinesterase Therapy in Post‐Polio Syndromea

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Human growth hormone effect on serum IGF-I and muscle function in poliomyelitis survivors.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Normal concentrations of serum insulinlike growth factor-1 in late polio

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Étude psychometrique du questionnaire de dépression de Beck auprès d'un échantillon d'étudiants universitaires francophones

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Quantitative motor assessment in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Muscular weakness assessment: use of normal isometric strength data. The National Isometric Muscle Strength (NIMS) Database Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Lack of an association between insulin-like growth factor-I and body composition, muscle strength, physical performance or self-reported mobility among older persons with functional limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

The potential of insulin-like growth factor-I as a therapeutic for the treatment of neuromuscular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Estrogen protects primary cortical neurons from glutamate toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Role of IGF-I in muscular atrophy of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900459-7

7 January 2021

Identifiers

10.1016/S0022-510X(00)00459-7

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11137515

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53502534&oldid=1394499541"